We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$43.4B
AUM Growth
+$3.14B
Cap. Flow
-$115M
Cap. Flow %
-0.27%
Top 10 Hldgs %
13.22%
Holding
2,192
New
164
Increased
795
Reduced
936
Closed
172

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$189M
2
WMB icon
Williams Companies
WMB
+$155M
3
AYX
Alteryx Inc
AYX
+$94.1M
4
ABBV icon
AbbVie
ABBV
+$87M
5
AMGN icon
Amgen
AMGN
+$78.1M

Sector Composition

Rank Sector Weight
1 Technology 17.44%
2 Healthcare 17.1%
3 Financials 12.78%
4 Industrials 10.38%
5 Consumer Discretionary 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAC icon
476
Macerich
MAC
$6.37B
$15M 0.03%
869,741
+44,444
+5% +$725K
URI icon
477
United Rentals
URI
$61.5B
$14.9M 0.03%
20,616
-1,932
-9% -$1.24M
BRKR icon
478
Bruker
BRKR
$8.52B
$14.9M 0.03%
158,215
+20,686
+15% +$1.66M
SDHC icon
479
Smith Douglas Homes
SDHC
$90.4M
$14.8M 0.03%
+500,000
New +$14M
BLBD icon
480
Blue Bird Corp
BLBD
$1.98B
$14.8M 0.03%
386,989
+207,366
+115% +$6.35M
NBIX icon
481
Neurocrine Biosciences
NBIX
$15.2B
$14.8M 0.03%
107,237
-1,340
-1% -$183K
COKE icon
482
Coca-Cola Consolidated
COKE
$13.4B
$14.7M 0.03%
173,900
-1,980
-1% -$171K
WLK icon
483
Westlake Corp
WLK
$8.93B
$14.7M 0.03%
96,051
-96,056
-50% -$13.5M
A icon
484
Agilent Technologies
A
$42.4B
$14.6M 0.03%
100,325
-3,169
-3% -$434K
THC icon
485
Tenet Healthcare
THC
$21B
$14.6M 0.03%
138,589
+27,508
+25% +$2.47M
CHD icon
486
Church & Dwight Co
CHD
$22.5B
$14.5M 0.03%
139,291
-3,298
-2% -$330K
DT icon
487
Dynatrace
DT
$15.9B
$14.5M 0.03%
312,173
+22,345
+8% +$1.16M
COLM icon
488
Columbia Sportswear
COLM
$2.88B
$14.3M 0.03%
176,558
+14,292
+9% +$1.14M
RAMP icon
489
LiveRamp
RAMP
$2.29B
$14.2M 0.03%
410,257
-5,190
-1% -$191K
IP icon
490
International Paper
IP
$17.9B
$14.1M 0.03%
361,983
+88,054
+32% +$3.19M
DPZ icon
491
Domino's
DPZ
$10.3B
$14.1M 0.03%
28,296
+3,700
+15% +$1.61M
TFX icon
492
Teleflex
TFX
$5.47B
$14M 0.03%
61,723
+714
+1% +$170K
BDN
493
Brandywine Realty Trust
BDN
$503M
$13.9M 0.03%
2,888,348
-129,593
-4% -$601K
CSTM icon
494
Constellium
CSTM
$3.45B
$13.8M 0.03%
624,241
+34,965
+6% +$677K
PEN icon
495
Penumbra
PEN
$12.5B
$13.8M 0.03%
61,750
-10,765
-15% -$2.66M
BLDR icon
496
Builders FirstSource
BLDR
$6.47B
$13.7M 0.03%
65,893
-25,198
-28% -$4.66M
ENPH icon
497
Enphase Energy
ENPH
$4.8B
$13.7M 0.03%
113,451
+55,606
+96% +$6.49M
VNT icon
498
Vontier
VNT
$4.37B
$13.6M 0.03%
299,280
+24,426
+9% +$953K
CMC icon
499
Commercial Metals
CMC
$7.2B
$13.6M 0.03%
230,910
-29,830
-11% -$1.58M
XPOF icon
500
Xponential Fitness
XPOF
$161M
$13.6M 0.03%
820,000
-480,000
-37% -$5.9M

Similar funds

Federated Hermes's Q1 2024 Portfolio in Review

As of Q1 2024, Federated Hermes held 2,192 positions worth $43.4B, up 7.8% from $40.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Federated Hermes's Q1 2024 filing shows 164 new, 795 increased, 936 reduced and 172 closed positions. Its largest new stake was Kanzhun: 4,861,533 shares worth $85.2M. The largest sale was Medtronic, an estimated $189M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Federated Hermes's largest Q1 2024 buy was Kanzhun: 4,861,533 shares worth $85.2M.
  • Federated Hermes added most to Bristol-Myers Squibb in Q1 2024, an estimated $193M increase.
  • Federated Hermes's biggest Q1 2024 reduction was Medtronic, cutting an estimated $189M.
  • Federated Hermes fully exited Alteryx Inc in Q1 2024, selling an estimated $94.1M.
  • Federated Hermes's ten largest holdings make up 13% of its $43.4B portfolio in Q1 2024.
  • Federated Hermes opened 164 new positions and closed 172 in Q1 2024.
  • Federated Hermes's portfolio value rose 7.8% quarter-over-quarter to $43.4B.

Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.